Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies (clinicaltrials.gov) - Sep 21, 2026 - P=N/A | N=1500 | Enrolling by invitation | Sponsor: Kite, A Gilead Company | N=1000 ➔ 1500
Enrollment change • Hematological Malignancies • Immunology • Oncology
|